Introduction
Heart disease is the leading cause of mortality and morbidity worldwide (Karantalis & Hare 2015) . Although, multiple therapeutic, medical and surgical approaches have been developed to delay and treat the progression of the disease process, beside heart transplantation, a therapeutic approach for permanent cure of the damaged heart following myocardial infarction or heart failure remains elusive (Davis et al. 2000 , Karantalis & Hare 2015 . Recent progress in stem cell research for tissue regeneration highlights the potential use of pluripotent adult stem/precursor cells to reconstruct or regenerate various tissues without comprising ethical issues (Nesselmann et al. 2008 , Karantalis & Hare 2015 , Singh et al. 2016 . In this context, multipotent mesenchymal stem cells (MSC) that are capable of converting into different cell types have gained attention to serve as a therapeutic tool for permanently repairing/regenerating the damaged heart tissue. The MSCs are of mesodermal origin and can differentiate into various cell types (endothelial cells, osteoblasts, chondrocyte, adipocyte, myocyte) when exposed to specific growth factors, signaling molecules and transcription factors (Karantalis & Hare 2015) . More importantly, they can be cultured and primed for delivery in an in vitro setting (Karantalis & Hare 2015) . MSC can be isolated from multiple sources (adipose tissue, placenta, gut, lung, liver, amniotic fluid, dental pulp, periodontal pulp, heart). Taken together, the multiple tissue sources and pluripotent nature of MSC, together with the ease of in vitro expansion, makes them an attractive therapeutic tool for treating heart damage.
The last decade has seen multiple animal as well as clinical trials assessing the therapeutic potential of MSC in repairing cardiac damage and function (Nesselmann et al. 2008 , Singh et al. 2016 . Although many (not all) studies have established the potential improvement in neovascularization, scar reduction and functional recovery, a major pitfall of MSC therapy is the low retention of transplanted cells, i.e. 0.44% of transplanted MSC resided in myocardium after 4 days (Toma et al. 2002 , Müller-Ehmsen et al. 2006 . This has led to a call for further optimization of MSC therapy by identifying molecules that could be used to prime/treat MSC or the recipient(s) to increase MSC homing-in and retention (Ray & Novotny 2008) . Since androgens have been shown to stimulate growth and influence cardiovascular cell's activity (Liu et al. 2003 , Ikeda et al. 2005 , together with the fact that they promote growth and angiogenesis in progenitor endothelial cells and stem cells (Cai et al. 2016), we hypothesize that androgen(s) may also facilitate MSC growth and homing-in in the heart tissue. Our hypothesis together with the fact that stem cell therapy is likely to be used in ageing men with low androgen levels (Gupta et al. 2008 ) may be of clinical relevance as pretreatment of recipients with androgen(s) may facilitate higher retention of transplanted cells.
To test our hypothesis, in this study, we assessed the effects of DHT, which is an androgen analog that is not converted to estrogen and selectively induces its biological effects via ARs, on the growth, migration and integration of MSC into cardiac slices. Using MSC co-cultured with cardiac tissue slices, we assessed the modulator effects of DHT on key actors (MMPs, VEGF-1, NO) of the pathways actively involved in tissue repair process such as proteolysis of fibrotic/ scar tissue to promote MSC adhesion, angiogenesis/ growth (proliferation, migration) and tissue repair. We report here that stimulation of MSC with DHT induces increased cell proliferation, migration and chemotaxis potentially via mechanism(s) involving ARs and MMPs, enhances cell migration toward the cardiac tissue slices and generate augmented secretion of angiogenin, VEGF and NO, factors involved in the invasion and integration of cells into ischemic tissues.
Materials and methods

Cell culture
Human MSCs were isolated from Wharton's jelly (WJ) and characterized as previously described (Corotchi et al. 2013) . All the procedures were approved by the Ethical Committee of the Institute of Cellular Biology and Pathology 'Nicolae Simionescu'. Morphological characterization of the cells was done using an inverted microscope (Nikon Eclipse TE300, Nikon) and a digital camera system for imaging (Nikon Digital Net Camera DN100, Nikon).
Adherence and proliferation assays
WJ-derived MSCs were plated at a density of 25 × 10 4 cells per 75 cm 2 flasks in the presence of 1, 30 and 100 nM DHT. The adherence and proliferation of DHT-treated MSC was determined in real-time using the xCELLigence and E-plate 16-View system (Roche). Briefly, after the cells were seeded onto the E-plate, various concentrations of DHT (AppliChem GmbH,
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Darmstadt, Germany) were added at time 0 and maintained for the entire period of the experiment. Automatically, the impedance values of each well were monitored by the xCELLigence system for 160 h. Based on cell impedance, the software monitored the cell index (CI) value, which is directly correlated with the cell number per well. We have used the RTCA DP 1.2.100 Software that allows to select different display possibilities, and we choose a linear graphic (which skips the lag phase) for a representative evolution in time of the treatment-dependent cell proliferation rate. The experiments were done three times in duplicate.
To verify the results obtained from the proliferation assay and get an accurate measure of cell number, we applied for DNA determination using the CyQuant Cell Proliferation Kit from Thermo Fisher Scientific, following the manufacturer instructions.
Real-time PCR technique
The mRNA gene expression for AR, EMMPRIN, MMP-2, MMP-9 and GAPDH was assessed by real-time PCR system (Applied Biosystems 7900HT, Life Technologies). Briefly, after 96 h in culture of DHT-treated and non-treated MSC, total RNA was extracted using PureLink RNA Mini Kit (Life Technologies). The RNA concentration was measured with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific). The cDNA synthesis was done using 1 µg of total RNA. The cDNA samples were amplified (in triplicates) for 40 cycles (95°C for 2 min, 95°C for 5 s, 60°C for 10 s, 72°C for 15 s and a dissociation cycle at 95°C for 15 s and 60°C for 15 s.) with specific oligonucleotide primers for AR, EMMPRIN, MMP-2, MMP-9 and GAPDH, as endogenous control. The primers used are shown in Table 1 . As negative controls, unstimulated cells were employed. Data were expressed as means of fold expression (relative quantification) values and positive (±)
s.e.m. of each gene in comparison with non-treated MSC and normalized to an arbitrary value of 1. Significant P values were calculated from ΔΔCt values with analysis of variance (ANOVA) tests.
Western blot assay
MSCs were cultured (96 h) in the absence or presence of DHT (30 nM). After two washes in PBS, cell lysates were prepared using Pierce Lysis Buffer, Halt Protease Inhibitor Single-Use Cocktail (Thermo Fisher Scientific) and a 10-min centrifugation at 14,000 g. Equal amounts of proteins from cell lysates were separated on 10-12% SDS-polyacrylamide gels (Invitrogen) under denaturing conditions and transferred onto Roti-PVDF 2.0 membrane transfer (Carl Roth GmbH + Co. KG, Karlsruhe, Germany). Non-specific binding was blocked with 2% non-fat dry milk or BSA (2 h) in TBS (SantaCruz Biotechnology). The membranes were incubated overnight (at 4°C) with the following specific antibodies (dilution 1/1000): antihuman AR: PA5-16750 (Thermo Fisher Scientific); antihuman MMP-2: AV20016 and anti-human MMP-9: AV33090 (Sigma-Aldrich Chemie GmbH); anti-human VEGF: MAB293R, anti-human Angiogenin: AF265, and anti-human EMMPRIN: AF972 (R&D Systems). After TBS washings, the membranes were incubated with the corresponding HRP-conjugated secondary antibodies: anti-rabbit-HRP: AB6721 (Abcam); anti-mouse HRP: A9044 (Sigma-Aldrich), dilution 1/200, 1 h at room temperature and examined by chemiluminescence (SuperSignal West Femto Maximum Sensitivity Substrate, Thermo Fisher Scientific). For control of protein loading, anti-beta-actin antibody (Santa Cruz Biotechnology) was used. The blots were scanned using a bioimaging system (ImageQuant LAS-3000 Chemiluminescence & Fluorescence Imaging System, Fujitsu Life Sciences, Tokyo, Japan). Target signals were normalized against beta-actin and analyzed semi-quantitatively using the NIH Image system (ImageJ).
Determination of NO produced by DHT-treated MSC
These measurements were performed using the inNO-T system according to the published protocol (Alexandru et al. 2011) . The NO released by MSC was measured after stimulation with 1, 30 and 100 nM DHT added at 10-min interval. In addition, to reveal the role of AR in 
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DHT-induced NO liberation, the cultured MSCs were stimulated for 45 min with an AR antagonist, flutamide (Sigma-Aldrich), and then the medium was changed and the NO measurements were taken.
Preparation of murine cardiac tissue slices
Experiments were done accordingly to the guidelines of the local animal welfare committee and approved by the ethical commission of the Institute of Cellular Biology and Pathology 'Nicolae Simionescu'. Under proper anesthesia, the hearts were removed from C57 black mice, and tissue slices were obtained using a vibratome apparatus according to Pillekamp and coworkers (Pillekamp et al. 2007) . The sections were transferred in DMEM (1×) and GlutaMAX-I (Life Technology) containing 10% FBS (Life Technology) and kept in the incubator under normoxic conditions (37°C, 5% CO 2 , 21% O 2 ).
Evaluation of the interaction of MSC with cardiac tissue by chemotaxis assay
xCELLigence system is a definite technique for real-time measurement of cell migration (Bird & Kirstein 2009 ). We employed CIM plates, which are composed of two chambers separated by a porous membrane. We placed in the lower chamber, one murine cardiac slice and in the upper chamber 40 000 MSCs that were stimulated with DHT or exposed to the vehicle (controls). In both chambers, DMEM (1×) with GlutaMAX and 10% FBS and 1% Antibiotic Antimycotic Solution (Sigma-Aldrich) was used. The CIM plates were kept in an incubator under normoxic conditions (as above). To evaluate the role of ARs in the migration process, MSCs in the CIM plate system were exposed to flutamide for 45 min prior to the experiment. The cell migration was monitored for 12 h. The determinations were done in quadruplicate, and the experiments were repeated at least three times.
Analysis of proteins secreted by MSC upon interaction with cardiac tissue by ELISA and Luminex techniques
For these experiments, 24 mm Transwell with 0.4 µm pore polycarbonate membrane inserts and TC treated (Corning) were used. Murine heart slices were placed in the lower chamber and 40,000 MSCs/well treated or not with DHT were placed in the upper chamber. Both cells and tissues were maintained in DMEM medium (1×) with GlutaMAX containing 10% FBS, 1% antibiotic antimycotic solution and were kept in an incubator under normoxic conditions.
For each experimental condition, after 24 and 48 h, 1.5 mL of conditioned medium was harvested from the lower chamber and MMP-2 and MMP-9 were determined by ELISA assay. Similar experiments were performed to assess angiogenin and VEGF by Luminex technique using Human Angiogenic Panel A (BD Bioscience) according to the manufacturer's protocols.
Detection of MSC adherence and integration into cardiac tissue slices by immunohistochemistry
In a 48-well TC-treated plate (Corning), 250 µm thick murine heart slices were placed in DMEM medium (1×) with GlutaMAX, 10% FBS CS and 1% antibiotic antimycotic solution. Then, 40,000 MSC/well non-treated or treated with DHT for 96 h prior to co-cultivation were seeded in direct contact with the heart slices. After 72 h, the heart fragments were washed twice with PBS and subjected either to immunohistochemical staining or to DNA quantification for cell counting (see below). For immunohistochemistry, the heart fragments were fixed overnight in 4% paraformaldehyde, embedded in paraffin, 2 µm sections cut with a microtome (DTK-2000, Dosaka, Kyoto, Japan), placed on slides, deparaffinized and rehydrated with successive concentrations of xylene and ethanol (100, 95, 70 and 50%). To ease the binding of antibodies, the heat-induced epitope retrieval was performed by placing the sections kept in sodium citrate buffer in a pressure cooker for 3 min. To evaluate the integration of human MSC in the murine ventricular slices, we have employed anti-human nuclei antibody (1:100, Sigma-Aldrich) followed by anti-mouse HRP: A9044 (Sigma-Aldrich). As substrate for the detection system, we used 3,3′-diaminobenzidine (DAB) (SigmaAldrich) that formed a brown color precipitate in the presence of HRP and H 2 O 2 .
Determination of MSC adherence and integration into cardiac tissue slices by DNA quantification using qRT-PCR
For these experiments, we have used Real-time PCR 7900 HT (as described earlier) TaqMan Universal PCR Master Mix-4304437, Human GAPDH-Hs03929097_g1 and a 384-well PCR plate (Thermo Fisher Scientific). Human MSCs (40,000 cells), untreated or DHT treated (30 nM), were incubated as described earlier for immunocytochemistry experiments. After 48 h, the DNA was isolated using the PureLink Genomic DNA Minikit (Life Technologies) and quantified by NanoDrop ND-1000
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UV-VIS spectrophotometer. For the calibration curve, serial 10-fold dilutions of standard DNA isolated from 2500 to 40,000 MSCs were prepared. Standard curves and the amplification conditions were established as in study by Àlvarez (Àlvarez et al. 2013 ). In addition, human vs mouse genes comparison was assayed using GenomeArtist (Ecovoiu et al. 2016) . The experimental conditions for the PCR were set according to the manufacturer specification. All experiments were performed in triplicate.
Liquid chromatography-mass spectrometry (LC-MS) analysis of MSC
All reagents were of electrophoresis or LC-MS grade. Urea, sodium deoxycholate (DOC), trizma hydrochloride (Tris-HCl), dl-dithiothreitol (DTT), iodoacetamide (IAA), N-acetyl-l-cysteine (NAC), ammonium bicarbonate and MS solvents were from Sigma-Aldrich. Trypsin Gold was from Promega, the protease inhibitors from Roche and solid phase extraction C18 columns from Waters (Milford, MA, USA). ADV-01A kit from Tebu-Bio (Le Perray-enYvelines, France) was employed for protein quantification. The cells were washed twice with PBS, centrifuged and the pellet was solubilized in a denaturant buffer containing 8 M urea, 1% DOC, 0.1% Tris-HCl (pH 8.8) and protease inhibitors, using sonication pulses for 30 s, on ice (UP50H from Hielscher, Teltow, Germany). Protein purification, carbamydomethylation, proteolysis and solid-phase extraction were performed as previously described .
LC-MS/MS analysis was carried out using the EASY n-LC II system (Thermo Scientific) coupled to the LTQ Orbitrap Velos Pro mass spectrometer (Thermo Scientific), working in a Top12 data-dependent analysis, with 60 k resolution, as described . Three biological replicates, each with three technological replicates were processed and analyzed for the proteomics workflow. The bioinformatics analysis comprised database protein inference, relative quantification and Kyoto Encyclopaedia of Genes and Genomes (KEGG) signaling pathways over-representation and was performed as previously described .
Statistical analysis
The data were analyzed by a one-way ANOVA either with the QtiPlot -0.9.8.9 (ProIndep Serv S.R.L., Craiova, Romania) or by two-tailed unpaired t tests with the GraphPad Prism 4 software (GraphPad Software).
The statistics are presented as mean ± s.e.m. and differences were considered statistically significant when P value was <0.05.
Results
DHT augments MSC proliferation without affecting their morphology
Since circulating levels of testosterone range between 8 and 42 nM/L, we first tested the effects of 1-1000 nM of DHT on the growth of MSCs. Treatment of MSCs with 1-1000 nM DHT-induced cell proliferation, but not cell death. Subsequently, we elected to use a concentration of 30 nM, which is comparable to the circulating levels of testosterone and induced MSC growth with no toxicity. Hence, this concentration was further used in most of the experiments. It must be emphasized that the circulating levels of DHT are 10-fold lower (≈3 nM) and its affinity for ARs is ≈3-fold higher than that of testosterone.
Examination of MSC after 1 and 4 days in culture showed that the DHT-treated MSC exhibited a similar morphology and viability with the non-stimulated cells; however, a definite increase in cell density in stimulated cells compared to non-treated MSC was noticed (Fig. 1A) .
In addition, MSC proliferation was evaluated in realtime for 160 h using xCELLigence system. In this system, the quantification of the cellular index (CI) calculated from the cellular impedance measurements is directly proportional with the number of cells per well. Our experiments revealed that DHT-treated MSC exhibited a significantly increased CI compared to non-treated cells indicating enhanced proliferation of MSC in the presence of DHT (Fig. 1B) .
To verify and confirm that CI correlates directly to the increase in cell number, we performed a proliferation assay consisting in DNA quantification. The results showed that DHT stimulation increased the number of MSC with more than 20,000 cells per well after 6 days in culture, which is a 3-fold increase compared to control, cells treated with DMSO (vehicle) (Fig. 1C) . The data corroborate well with those obtained using xCELLigence system, showing that DHT stimulation induces an increase in MSC proliferation rate.
DHT induces in MSC upregulation of the gene expression of ARs and of the genes involved in cell migration, EMMPRIN and MMP-9
To find out whether DHT affects the gene expression of ARs and of other molecules implicated in cell migration, cultured MSC were exposed to the hormone (30 nM) and then subjected to qRT-PCR assay. The experiments revealed that DHT induced a significant upregulation of the mRNA for AR and of the molecules involved in cell migration, EMMPRIN and MMP-9; DHT had no effect on MMP-2 gene expression (Fig. 2) .
DHT induces changes in protein expression of AR, EMMPRIN, angiogenin and MMP-9
Western blot assay showed that, compared to nonstimulated cells, the DHT-treated MSCs exhibit a significant increase in protein expression of ARs, EMMPRIN, Significant P values are indicated in the graphics and calculated from arbitrary value ANOVA tests. n = 3. *P value <0.05.
Journal of Molecular Endocrinology
angiogenin and MMP-9. The expression of MMP-2 and VEGF were not modified by DHT as compared to the non-treated MSC (Fig. 3) . Remarkably, the DHT-induced changes in the protein expression of AR, EMMPRIN and MMP-9 were paralleled by comparable increase in their gene expression in MSCs (Fig. 2) .
DHT stimulates NO production in MSC via an AR mechanism
These experiments examined whether the MSCs respond to different DHT concentrations (1, 30 and 100 nM) by releasing increased concentration of NO in the culture medium; the NO production was monitored with a specific NO sensor. It was detected that, in the presence of different DHT concentrations, the MSC produced approx. 2.5-fold more NO compared with the values (baseline) obtained for non-treated MSC, and this was independent of the hormone concentrations ( Fig. 4A and B). In MSCs pretreated for 45 min with flutamide (10 µM), an androgen receptor antagonist, the stimulatory effects of DHT on NO secretion were blocked to basal levels, suggesting that the stimulatory effects of DHT on NO secretion are AR mediated (Table 2 ). These observations provide evidence that the concentration-dependent stimulatory effects of DHT on NO secretion are AR mediated.
DHT enhances migration of MSC toward the murine cardiac slices
To find out whether DHT influences the migration of MSC toward heart tissue, we set up co-culture experiments utilizing human MSC and murine cardiac tissue slices Figure 3 DHT increases significantly the protein levels of AR, EMMPRIN, MMP-9 and angiogenin in MSC. Cultured cells were stimulated with 30 nM DHT and subjected to Western blot assay. As shown earlier by gel electrophoresis and morphometric analysis, compared to non-stimulated MSC (controls), DHT induces a significant increase in protein expression of androgen receptor (A, AR), EMMPRIN (B), MMP-9 (D) and angiogenin (F) and has no effect on MMP-2 (C) and VEGF (E). All the results were normalized to beta-actin; *P value <0.005 in comparison with control cells were considered statistically significant. n = 3.
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(250 µm thick). The results obtained using xCELLigence system showed that the rate of migration of hormonetreated MSC toward the cardiac tissue was constantly higher than the values obtained for migration of control or vehicle-exposed cells. The migration of stimulated MSC was about two folds higher during and at the end of the 14 h of measurements. To find out if ARs are involved in cell migration toward heart, we performed similar experiments in the presence of flutamide, to impair the hormone action by blocking its receptor ( Fig. 5A and  B) . The results showed that blocking the ARs, the cell migration, as expressed by the CI, was limited to the values obtained in controls.
DHT-treated MSCs exhibit increased adherence/integration into cardiac slices
To validate the earlier results and achieve robust evidence of MSC migration and integration into murine cardiac slices, we apply for immunohistochemical staining using anti-human nuclei antibody that could detect particularly human MSC within the sections. Examination of the tissue sections incubated with anti-human nuclei antibody followed by an HRP-labeled secondary antibody revealed the brownstained MSC nuclei and the blue, hematoxylin stained, mouse cell nuclei. We found that in comparison with non-treated MSC, the number of DHT-treated human MSC is considerably higher (Fig. 6A and B) . As antibody control, we used IgG isotype (Fig. 6C) . The data were validated by digital counting using ImageJ software indicating a significant difference between non-treated and treated MSC integration within heart tissue ( Fig. 6D) .
Because of the limited volume of tissue that can be examined by immunocytochemistry, we apply for a quantitative method, the qRT-PCR. Evaluation of human DNA revealed that the total number of human hormonetreated MSC adhered and integrated within the cardiac Figure 4 DHT-treated MSC exhibit augmented NO release. The cells were exposed in culture either to different concentration of DHT (1, 30, 100 nM) (A) either to flutamide (F) and DHT (B). NO release was determined in the culture medium using an amperometric NO sensor. Each measurement was done separately for t = 10 min; Baseline is considered 0 nM. Table 2 Quantification and statistical analysis of the NO concentration in the culture medium of MSC exposed to 1, 30 and 100 nM DHT in the absence or presence of flutamide. MSC integration into heart tissue by DHT
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slices was ~50% higher than that for the non-stimulated cells (Fig. 6E) .
Incubation of DHT-treated MSC with heart tissue increases the cell secretion of MMP-2 and MMP-9
To determine whether migration-stimulating factors are released after co-culture of stimulated MSC with cardiac slices, we employed a Transwell system in which the cells and the cardiac sections were placed in the upper and respectively lower chamber, which is in indirect contact. After 24 and 48 h, the culture medium was collected and analyzed using human-specific ELISA kits. We have detected that MMP-2 and MMP-9 were significantly increased, both at 24 and 48 h of co-cultivation of DHTtreated MSC with cardiac slices as compared to controls in which non-treated MSC were employed. The difference was, in particular, higher after 48 h (Fig. 7A , B, C and D).
Exposure of hormone-treated MSC to cardiac tissue slices upregulates the cell secretion of angiogenin and VEGF
Analysis by fluorescence-based multiplex cytokine assay (Luminex) of the conditioned medium collected from DHT-treated MSC incubated (in a Transwell system) with cardiac tissue slices revealed a significant upregulated secretion of angiogenin (at 24 and 48 h) and of VEGF at 48 h ( Fig. 7E and F) .
Upregulation of actin cytoskeleton in DHT-treated MSC as revealed by liquid chromatographymass spectrometry
A total of 3180 protein groups were unambiguously identified using high-resolution mass spectrometry, of which 2320 were identified in both groups, while 490 proteins could be uniquely attributed to the effects of DHT Figure 6 Identification of the integration of DHT-treated MSC into the heart tissue slices by immunohistochemistry. MSC were co-cultured for 48 h with heart tissue slices (250 µm thick) and then the tissue was washed and embedded in paraffin. The 2 µm sections were incubated with anti-human nuclei antibody followed by an HRP-labeled secondary antibody. The peroxidase reaction stains in brown the MSC nuclei, whereas the hematoxylin stains the mouse cell nuclei in blue. Note that in comparison with non-stimulated MSC (A), a significantly higher number of nuclei are stained (brown) in the heart slices co-cultured with DHT-stimulated human MSC (B). As antibody control, the IgG isotype was employed (C). In (D) digital counting of the results using ImageJ software shows that the number of stained human MSC nuclei is significantly higher in the case of stimulated cells (MSC + DHT). For each section, 4 different fields were analyzed (n = 3). (E) Quantification of the number of MSC adhered/integrated into heart slices after co-culture for 48 h assessed by human DNA analysis (qRT-PCR). n = 3. *<0.05 as compared to non-treated cells. M-A Popa, M-C Mihai et al. MSC integration into heart tissue by DHT 60 1 :
Journal of Molecular Endocrinology treatment on MSC (Fig. 8A) . The relative quantification experiments were based on precursor ion alignment and intensity comparison between the DHT-treated and the control MSC. A coefficient of variation of <30% was allowed between technical replicates. The total ion chromatogram normalization method resulted in 869 proteins that are differentially expressed following the treatment with DHT. A supplementary filtration, allowing only the proteins quantified with at least 2 peptides/protein, was chosen for further bioinformatics analysis. This resulted in a list of 258 proteins with spectral abundance alteration of at least 1.5-fold (DHT treatment/control samples) and statistical significance (Fig. 8B ). Among them, four proteins, which presented very high identification confidence (Mascot score >9000) and significant spectral alteration levels (Table 3) were found to be part of a key cell motilitysignaling map, the regulation of actin cytoskeleton (KEGG entry hsa04810). This pathway was found to be statistically over-represented, after the implementation of a further significance correction, which was based on the false discovery rate algorithm (FDR P value: 1.96E-2).
Discussion
The pluripotent nature of adult MSC is of great therapeutic interest to treat heart damage following myocardial infarction, reperfusion injury succeeding ischemia and heart/vascular damage. Certainly, it may provide the only alternative to heart transplantation as a permanent cure for heart damage (Nesselmann et al. 2008 , Karantalis & Hare 2015 , Singh et al. 2016 . The availability of MSC from multiple body sources and the fairly simple in vitro propagation of the cells to the desired cell type as well as the lack of ethical problems have made these cells a favorite source for stem cell therapy. The last decade has seen multiple animal and clinical studies assessing the efficacy of MSC in repairing damaged heart (Singh et al. 2016) . Although, MSC-induced protective effects were The experiments were performed in Transwell plates, for 24 and 48 h, and the proteins were quantified by ELISA and Luminex assay using human antibodies (to evidence human MSC). *P < 0.05; **<0.001, ##P value <0.005 in comparison with control cells (non-stimulated) were considered statistically significant. n = 3.
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observed in most, but not all, studies, the consensus is that the integration of MSC is low and novel strategies promoting their homing-in and integration need to be further developed to make MSC therapy successful. Sex steroids are known to directly affect human bone marrow stromal cells; however, the biological mechanisms involved remain unclear. In vitro experiments revealed that male sex hormones, i.e. androgens, induce endothelial cell growth, suggesting that androgens may influence the cardiovascular system via angiogenic actions (Sieveking et al. 2010) . Thus, we set up experiments to find out whether exposure of MSC to androgens has a beneficial effect on the cell's characteristic functions. In prior experiments, we have used testosterone (Corotchi et al. 2016) to assess its effects on the growth of MSCs. We found that the growth stimulatory effects of testosterone and DHT were comparable, although testosterone was marginally more potent than DHT (MSC growth was induced, by approximately 3.86-fold and 3.4-fold, in response to testosterone and DHT, respectively). Hence, for further experiments, we employed DHT because it is a most potent testosterone derivative with the high affinity for AR, and it is not metabolized to estradiol.
The following novel findings were revealed by our experiments with MSCs: (a) DHT increased proliferation, migration and chemotaxis via mechanism(s) involving ARs; (b) DHT modulated MMP-2 and MMP-9 levels; (c) enhanced cell migration toward cardiac tissue and (c) secretion of angiogenin, VEGF and NO -key factors involved in the invasion and integration of cells into ischemic tissue that attempts to regenerate.
We found that the secretion of MMPs is increased significantly in DHT-treated MSC, and this effect was specifically enhanced in the presence of heart slices. These results suggest the possibility that factors generated by ischemic tissue stimulates MSC to increase the MMPs production, and this response supports the proteolytic activity (Fig. 9) , which is essential for clearing damaged scar tissue so as to facilitate MSC integration and tissue repair. Taken together, the earlier findings suggest that DHT potentiates the integration of MSC into cardiac tissue, and thus, may positively influence the repair process.
The participation of MMP's and VEGF in angiogenesis is well established as they facilitate the cell migration and are pro-angiogenic factors (Ries et al. 2007 , Mias et al. 2009 ). The spatiotemporal regulation of MMP-2 and MMP-9 have been observed, following myocardial infarction and end-stage heart failure suggesting that they are involved in the cardiovascular remodeling (Deschamps & Spinale 2006) . Secreted MMPs are key markers for cell migration under normal and pathological conditions (Spinale & Wilbur 2009) . Increased presence of MMP-2 is indicative of deleterious recovery following ischemic heart injury, whereas sustained expression of MMP-9 facilitates recovery and post-ischemic heart reconstruction (Cheung et al. 2000) . Our observation that DHT induced MMP-9, but not MMP-2 in MSCs, suggests that DHT induces beneficial MMPs under normal conditions. The fact that MMP-2 secretion was Figure 8 Nano chromatography-mass spectrometric analysis of non-treated control MSCs and DHT-treated MSCs. (A) Qualitative analysis revealed the identification of 3180 proteins, of which 370 proteins were only attributed to non-treated MSCs, while 490 proteins were uniquely identified in the samples following DHT treatment; (B) the label-free relative mass spectrometric quantification demonstrated the spectral abundance alteration of 869 proteins (blue dots), 258 of them being quantified with at least 2 peptides/protein (dark-blue dots), passing the abundance ratio (vertical lines signify the log 2 normalized ratio of 0.67 and 1.5, respectively) and the significance criteria (horizontal line represents the -log 10 P value of 0.05).
induced, when MSCs were co-incubated with heart slices suggests that factors generated from sliced (injured) heart trigger MMP-2 generation to potentially facilitate early proteolytic activity for clearing the scar tissue and to facilitate subsequent angiogenic and tissue growth/ integration process (Ries et al. 2007 , Mishra et al. 2013 , Nam et al. 2015 . The observation that DHT attenuated MMP-2 expression in MSCs co-incubated with heart slices after 48 h, but increased MMP-9 expression suggests that DHT regulates MMP-2 and MMP-9 in a spatio-temporal fashion to facilitate tissue recovery.
Both MMP-2 and MMP-9 possess gelatinase activity and have a considerable overlap in substrates they degrade; however, MMP-9 is incapable of direct proteolysis of collagen I (Klein & Bischoff 2011) . Evidence also suggests that MMP-2 and MMP-9 have distinct roles in tissue remodeling, and these effects are regulated in a spatiotemporal fashion by paracrine factors generated following injury (Ries et al. 2007 , Klein & Bischoff 2011 , Mishra et al. 2013 , Nam et al. 2015 . Knockout models of MMP-9 exhibit delayed apoptosis, vascularization and ossification of hypertrophic chondrocytes. MMP-2 degrades extracellular matrix (ECM) protein and cleaves other non-ECM substrates including pro-TNF, FGF receptor-1, TGF-B, IL-1B and various chemokines. Treatment with DHT increased the expression of MMP-9, and EMMPRIM in MSC suggests that androgens can potentially activate mechanisms critical for initiating tissue repair and remodeling. This would be similar to the reported sprouting angiogenesis in endothelial cells, which release proteolytic enzymes, including MMPs and VEGF in order to induce angiogenic signaling efficiently (Wu et al. 2007 , Cai et al. 2016 . Our findings also demonstrate that the stimulatory effects of DHT on the expression of both, cell migration and pro-angiogenic factors, such as MMP-9, VEGF and angiogenin are maintained up to 48 h. These results imply that MSC could be involved in angiogenesis either through differentiation or via a paracrine effect. Furthermore, we demonstrate that DHT enhanced chemotaxis of MSC toward the cardiac slices and stimulated their adhesion and integration within this tissue. Our findings suggest that synthesis of MMPs is potentially influenced by EMMPRIN, could regulate myogenic cell differentiation (Mohamed et al. 2011) and provide the first evidence for an association between EMMPRIN and MMPs in a co-culture model using hormone-treated MSC.
At the functional level, our results demonstrate that cultured human MSC are capable of synthesizing NO constitutively. Moreover, we provide evidence that stimulation of MSC with androgens increased the NO release as measured in real time in the culture medium, and this secretion is blocked in the presence of the AR antagonist. The significance of the increase in constitutive NO production in MSC can only be speculated. Since NO is a key mediator for angiogenesis (Losordo & Isner 2001) , we assume that stimulation of basal NO production by DHT in human MSC participates in promoting/improving the capillary network around the ischemic sites. Our observation that DHT induces both VEGF and NO suggests that the pro-angiogenic effects of DHT may be mediated via a cross-talk between them. Moreover, this may create Data include the Uniprot database accession entry, molecular weight and median Mascot identification score. ***P < 0.001.
Figure 9
Schematic representation of DHT-induced pro-repair mechanisms in MSCs.
Our data indicate that DHT stimulates proliferation and migration of MSC by a process in which increased expression of EMMPRIN, MMP-9 potentially promotes their homing-in and cardiac integration. Additionally, DHT induces expression of angiogenin, VEGF and of AR-dependent NO release that may participate in the process of angiogenesis and vasculogenesis.
a synergistic environment as VEGF has been shown to induce angiogenesis via NO generation and NO induces VEGF thereby creating a positive feedback angiogenic loop (Papapetropoulos et al. 1997 , Losordo & Isner 2001 , Ikeda et al. 2012 .
The experiments showing that the number of DHTtreated MSC integrated in the cardiac slices was higher than that of non-treated cells provide evidence that the hormone facilitates homing-in and integration of MSC. The fact that quantification of the integrated cells was assessed using 2D techniques, which monitor cells stained within the 2nd or 3rd layer at a depth of ≈2 µm within the tissue reaffirms the notion that DHT promotes MSC integration deep within the tissue and the changes observed are not simply due to superficial MSC adherence. Although our findings provide evidence that DHT increases MSC integration, whether the cells differentiate into endothelial or cardiomyocytes was not ascertained. Based on pilot studies, treatment of MSC with DHT did not change the cell's phenotype; however, whether they change while residing within the tissue environment remains unknown. Since the studies were conducted for a maximum of 72 h because of limited cardiac sections viability, it is unlikely that the MSCs differentiate into ECs or cardiomyocytes. The secretion of MMPs and pro-angiogenic molecules by MSCs indicates the pro-angiogenic potential of hormone-stimulated cells. Further long-term studies are required to monitor the fate of DHT-stimulated MSC in the heart.
The mass-spectrometric results identified integrin β1 as differentially regulated (1.8-fold) by the DHT treatment. This is concurrent with other findings which demonstrate that β-integrins are essential in MSC attachment to tissue lesions (Zwolanek et al. 2015) . In addition, the DHTinduced upregulation of myosin-9 could have a possible implication in the increased actomyosin assembly contraction. Together, these and other proteins (Table 3) participate in actin cytoskeleton rearrangement processes, data that corroborate well with our findings that MSC migration is enhanced by the DHT treatment.
The clinical relevance of our findings can only be speculated. For instance, DHT may be of therapeutic relevance in enhancing MSC integration and cardiac repair. Our findings suggest that priming of MSC may amplify the chances of their success to repair a damaged heart. However, additional in vivo studies are necessary to confirm this possibility. Although our findings suggest that DHT may promote MSC-induced cardiac repair, androgen substitution in elderly men has been shown to induce both deleterious (Budoff et al. 2017 ) and protective actions in older men (Ikeda et al. 2005 , 2012 , Liu et al. 2014 . Moreover, androgens as well as ARs have been shown to induce cardiac growth, and drop in androgen levels is associated with cardiovascular disease (Dubey et al. 2002) . Since MSC integration would require shortterm exposure to DHT-primed MSCs, it is feasible that its beneficial actions may override its, potential, long-term deleterious effects. However, in vivo studies are required to confirm this possibility.
Although our in vitro findings provide evidence that DHT promotes MSC integration in cardiac tissue, in vivo proof for this is still lacking. Another limitations of the study include the fact that impact of androgens, whether beneficial or deleterious, on the cardiovascular system is still unclear (Ikeda et al. 2005 , 2012 , Liu et al. 2014 , Budoff et al. 2017 . It is feasible that short-term treatment with DHT-primed MSCs may not have the same deleterious effects as in subjects taking androgen substitution; however, this possibility needs to be further investigated. MSC can evolve into many different cell types, including bone cells (Zomorodian & Baghaban Eslaminejad 2012) . Since calcification of the blood vessels leads to cardiovascular disease, the treatment with MSC should be cautiously controlled for the possible deleterious side effects and needs to be further investigated.
Finally, the rationale for using 30 nM DHT concentrations in the present study was that the value was comparable to testosterone. Moreover, unlike testosterone, DHT is not metabolized to estradiol thereby resulting in AR-specific actions. However, it should be noted that circulating levels of DHT are 10-fold lower (≈3 nM), and its affinity for AR is ≈3-fold higher. Hence, the concentrations in the present study may not represent levels that would result in the typical androgenic response. However, our finding that NO synthesis was induced by low (1 nM) as well as high (30 and 100 nM) concentrations of DHT suggests that the effects of 30 nM are AR mediated. Moreover, in preliminary growth studies, physiological concentrations of DHT induced MSC growth and migration, suggesting that the effects of high 30 nM DHT were mimicked by physiological concentrations of DHT. Our contention that 30 nM DHT induces pro-angiogenic factors and assists homing of MSCs into cardiac tissue is supported by findings from Borst and coworkers who demonstrated that supraphysiologic testosterone treatment improved recovery from cardiac ischemic reperfusion injury (Borst et al. 2010) .
Although our findings suggest that culturing MSC with DHT may allow for better incorporation into cardiac tissue, in a manner independent from systemically Journal of Molecular Endocrinology elevated androgen concentrations. However, from a translational perspective, some preclinical and clinical evidence indicates that DHT may be detrimental to cardiac function. For example, Shores and coworkers reported that high circulating DHT is associated with cardiovascular disease and all-cause mortality in men (Shores et al. 2014) . Rubio-Gayosso and coworkers also reported that 5-alphareductase inhibition resulted in myocardial protection after cardiac ischemic reperfusion injury and that DHT treatment increased myocardial damage resulting from ischemic reperfusion injury (Rubio-Gayosso et al. 2013) . Hence, more studies using physiologic concentrations of DHT are required to further test its impact on tissue remodeling and cardiovascular repair.
In conclusion, we provide the first evidence that DHT induces growth, proliferation and migration of MSC and promotes integration of these cells into cardiac tissue in vitro. These effects are accompanied by upregulation of ARs and of key molecules known to promote tissue remodeling and angiogenesis (EMMPRIN, MMP-2, MMP-9, VEGF, angiogenin, NO). Our findings suggest that priming of MSC with DHT may functionally increase their capability to repair and regenerate cardiac tissue. However, in vivo studies using DHT-primed MSCs are necessary to confirm our in vitro observations. MSC integration into heart tissue by DHT
